Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Diabetes Testing Program Market Research Report 2026
Global Diabetes Testing Program Market Research Report 2026
Industry: Medical Devices & Consumables
Published Date: 2026-01-05
Pages: 126 Pages
Report ld: 5520275
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Diabetes Testing Program Market Size(US$)
CAGR 2026-2032
7.5%
Market Size,2032
USD 4,414
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 2,855 million
Market Forecast in 2032(Value)
US$ 4,414 million
CAGR
7.5%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Diabetes Testing Program market was valued at US$ 2674 million in 2025 and is anticipated to reach US$ 4414 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
The Global key players of Diabetes Testing Program include Roche, LifeScan, Abbott Laboratories, etc. The top three players hold a share over 44%. China is the largest market, and has a share about 33%. In terms of product type, HbA1c Test is the largest segment, which occupied for a share of about 66%. For application, Home Test is the largest segment, which has a share about 42%.
This report delivers a comprehensive overview of the global Diabetes Testing Program market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Diabetes Testing Program. The Diabetes Testing Program market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Diabetes Testing Program market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Diabetes Testing Program manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- Roche
- LifeScan
- Abbott Laboratories
- Ascensia
- Arkray
- I-SENS
- Omron
- Braun
- Siemens
- Bio-Rad Laboratories
- Tosoh
- Danaher Corporation
- Trinity Biotech
- HUMAN Diagnostics
- Terumo
- Sinocare
- Acon Biotech
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- HbA1c Test
- Finger-prick Test
Segment by Application
- Medical Diagnosis
- Home Test
- Lab Testing
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Diabetes Testing Program companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Testing Program Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 HbA1c Test
1.2.3 Finger-prick Test
1.3 Market by Application
1.3.1 Global Diabetes Testing Program Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Medical Diagnosis
1.3.3 Home Test
1.3.4 Lab Testing
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Testing Program Market Perspective (2021–2032)
2.2 Global Diabetes Testing Program Growth Trends by Region
2.2.1 Global Diabetes Testing Program Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Diabetes Testing Program Historic Market Size by Region (2021–2026)
2.2.3 Diabetes Testing Program Forecasted Market Size by Region (2027–2032)
2.3 Diabetes Testing Program Market Dynamics
2.3.1 Diabetes Testing Program Industry Trends
2.3.2 Diabetes Testing Program Market Drivers
2.3.3 Diabetes Testing Program Market Challenges
2.3.4 Diabetes Testing Program Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Testing Program Players by Revenue
3.1.1 Global Top Diabetes Testing Program Players by Revenue (2021–2026)
3.1.2 Global Diabetes Testing Program Revenue Market Share by Players (2021–2026)
3.2 Global Top Diabetes Testing Program Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Diabetes Testing Program Revenue
3.4 Global Diabetes Testing Program Market Concentration Ratio
3.4.1 Global Diabetes Testing Program Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Testing Program Revenue in 2025
3.5 Global Key Players of Diabetes Testing Program Head Offices and Areas Served
3.6 Global Key Players of Diabetes Testing Program, Products and Applications
3.7 Global Key Players of Diabetes Testing Program, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Diabetes Testing Program Breakdown Data by Type
4.1 Global Diabetes Testing Program Historic Market Size by Type (2021–2026)
4.2 Global Diabetes Testing Program Forecasted Market Size by Type (2027–2032)
5 Diabetes Testing Program Breakdown Data by Application
5.1 Global Diabetes Testing Program Historic Market Size by Application (2021–2026)
5.2 Global Diabetes Testing Program Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Diabetes Testing Program Market Size (2021–2032)
6.2 North America Diabetes Testing Program Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Diabetes Testing Program Market Size by Country (2021–2026)
6.4 North America Diabetes Testing Program Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetes Testing Program Market Size (2021–2032)
7.2 Europe Diabetes Testing Program Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Diabetes Testing Program Market Size by Country (2021–2026)
7.4 Europe Diabetes Testing Program Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Testing Program Market Size (2021–2032)
8.2 Asia-Pacific Diabetes Testing Program Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Diabetes Testing Program Market Size by Region (2021–2026)
8.4 Asia-Pacific Diabetes Testing Program Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Diabetes Testing Program Market Size (2021–2032)
9.2 Latin America Diabetes Testing Program Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Diabetes Testing Program Market Size by Country (2021–2026)
9.4 Latin America Diabetes Testing Program Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Testing Program Market Size (2021–2032)
10.2 Middle East & Africa Diabetes Testing Program Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Diabetes Testing Program Market Size by Country (2021–2026)
10.4 Middle East & Africa Diabetes Testing Program Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Diabetes Testing Program Introduction
11.1.4 Roche Revenue in Diabetes Testing Program Business (2021–2026)
11.1.5 Roche Recent Development
11.2 LifeScan
11.2.1 LifeScan Company Details
11.2.2 LifeScan Business Overview
11.2.3 LifeScan Diabetes Testing Program Introduction
11.2.4 LifeScan Revenue in Diabetes Testing Program Business (2021–2026)
11.2.5 LifeScan Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Diabetes Testing Program Introduction
11.3.4 Abbott Laboratories Revenue in Diabetes Testing Program Business (2021–2026)
11.3.5 Abbott Laboratories Recent Development
11.4 Ascensia
11.4.1 Ascensia Company Details
11.4.2 Ascensia Business Overview
11.4.3 Ascensia Diabetes Testing Program Introduction
11.4.4 Ascensia Revenue in Diabetes Testing Program Business (2021–2026)
11.4.5 Ascensia Recent Development
11.5 Arkray
11.5.1 Arkray Company Details
11.5.2 Arkray Business Overview
11.5.3 Arkray Diabetes Testing Program Introduction
11.5.4 Arkray Revenue in Diabetes Testing Program Business (2021–2026)
11.5.5 Arkray Recent Development
11.6 I-SENS
11.6.1 I-SENS Company Details
11.6.2 I-SENS Business Overview
11.6.3 I-SENS Diabetes Testing Program Introduction
11.6.4 I-SENS Revenue in Diabetes Testing Program Business (2021–2026)
11.6.5 I-SENS Recent Development
11.7 Omron
11.7.1 Omron Company Details
11.7.2 Omron Business Overview
11.7.3 Omron Diabetes Testing Program Introduction
11.7.4 Omron Revenue in Diabetes Testing Program Business (2021–2026)
11.7.5 Omron Recent Development
11.8 Braun
11.8.1 Braun Company Details
11.8.2 Braun Business Overview
11.8.3 Braun Diabetes Testing Program Introduction
11.8.4 Braun Revenue in Diabetes Testing Program Business (2021–2026)
11.8.5 Braun Recent Development
11.9 Siemens
11.9.1 Siemens Company Details
11.9.2 Siemens Business Overview
11.9.3 Siemens Diabetes Testing Program Introduction
11.9.4 Siemens Revenue in Diabetes Testing Program Business (2021–2026)
11.9.5 Siemens Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Details
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Diabetes Testing Program Introduction
11.10.4 Bio-Rad Laboratories Revenue in Diabetes Testing Program Business (2021–2026)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 Tosoh
11.11.1 Tosoh Company Details
11.11.2 Tosoh Business Overview
11.11.3 Tosoh Diabetes Testing Program Introduction
11.11.4 Tosoh Revenue in Diabetes Testing Program Business (2021–2026)
11.11.5 Tosoh Recent Development
11.12 Danaher Corporation
11.12.1 Danaher Corporation Company Details
11.12.2 Danaher Corporation Business Overview
11.12.3 Danaher Corporation Diabetes Testing Program Introduction
11.12.4 Danaher Corporation Revenue in Diabetes Testing Program Business (2021–2026)
11.12.5 Danaher Corporation Recent Development
11.13 Trinity Biotech
11.13.1 Trinity Biotech Company Details
11.13.2 Trinity Biotech Business Overview
11.13.3 Trinity Biotech Diabetes Testing Program Introduction
11.13.4 Trinity Biotech Revenue in Diabetes Testing Program Business (2021–2026)
11.13.5 Trinity Biotech Recent Development
11.14 HUMAN Diagnostics
11.14.1 HUMAN Diagnostics Company Details
11.14.2 HUMAN Diagnostics Business Overview
11.14.3 HUMAN Diagnostics Diabetes Testing Program Introduction
11.14.4 HUMAN Diagnostics Revenue in Diabetes Testing Program Business (2021–2026)
11.14.5 HUMAN Diagnostics Recent Development
11.15 Terumo
11.15.1 Terumo Company Details
11.15.2 Terumo Business Overview
11.15.3 Terumo Diabetes Testing Program Introduction
11.15.4 Terumo Revenue in Diabetes Testing Program Business (2021–2026)
11.15.5 Terumo Recent Development
11.16 Sinocare
11.16.1 Sinocare Company Details
11.16.2 Sinocare Business Overview
11.16.3 Sinocare Diabetes Testing Program Introduction
11.16.4 Sinocare Revenue in Diabetes Testing Program Business (2021–2026)
11.16.5 Sinocare Recent Development
11.17 Acon Biotech
11.17.1 Acon Biotech Company Details
11.17.2 Acon Biotech Business Overview
11.17.3 Acon Biotech Diabetes Testing Program Introduction
11.17.4 Acon Biotech Revenue in Diabetes Testing Program Business (2021–2026)
11.17.5 Acon Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Diabetes Testing Program Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of HbA1c Test
Table 3. Key Players of Finger-prick Test
Table 4. Global Diabetes Testing Program Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Diabetes Testing Program Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Diabetes Testing Program Market Size by Region (US$ Million), 2021–2026
Table 7. Global Diabetes Testing Program Market Share by Region (2021–2026)
Table 8. Global Diabetes Testing Program Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Diabetes Testing Program Market Share by Region (2027–2032)
Table 10. Diabetes Testing Program Market Trends
Table 11. Diabetes Testing Program Market Drivers
Table 12. Diabetes Testing Program Market Challenges
Table 13. Diabetes Testing Program Market Restraints
Table 14. Global Diabetes Testing Program Revenue by Players (US$ Million), 2021–2026
Table 15. Global Diabetes Testing Program Market Share by Players (2021–2026)
Table 16. Global Top Diabetes Testing Program Players by Tier (Tier 1, Tier 2, and Tier 3), based on Diabetes Testing Program Revenue, 2025
Table 17. Ranking of Global Top Diabetes Testing Program Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Diabetes Testing Program Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Diabetes Testing Program, Headquarters and Area Served
Table 20. Global Key Players of Diabetes Testing Program, Products and Applications
Table 21. Global Key Players of Diabetes Testing Program, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Diabetes Testing Program Market Size by Type (US$ Million), 2021–2026
Table 24. Global Diabetes Testing Program Revenue Market Share by Type (2021–2026)
Table 25. Global Diabetes Testing Program Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Diabetes Testing Program Revenue Market Share by Type (2027–2032)
Table 27. Global Diabetes Testing Program Market Size by Application (US$ Million), 2021–2026
Table 28. Global Diabetes Testing Program Revenue Market Share by Application (2021–2026)
Table 29. Global Diabetes Testing Program Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Diabetes Testing Program Revenue Market Share by Application (2027–2032)
Table 31. North America Diabetes Testing Program Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Diabetes Testing Program Market Size by Country (US$ Million), 2021–2026
Table 33. North America Diabetes Testing Program Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Diabetes Testing Program Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Diabetes Testing Program Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Diabetes Testing Program Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Diabetes Testing Program Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Diabetes Testing Program Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Diabetes Testing Program Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Diabetes Testing Program Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Diabetes Testing Program Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Diabetes Testing Program Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Diabetes Testing Program Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Diabetes Testing Program Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Diabetes Testing Program Market Size by Country (US$ Million), 2027–2032
Table 46. Roche Company Details
Table 47. Roche Business Overview
Table 48. Roche Diabetes Testing Program Product
Table 49. Roche Revenue in Diabetes Testing Program Business (US$ Million), 2021–2026
Table 50. Roche Recent Development
Table 51. LifeScan Company Details
Table 52. LifeScan Business Overview
Table 53. LifeScan Diabetes Testing Program Product
Table 54. LifeScan Revenue in Diabetes Testing Program Business (US$ Million), 2021–2026
Table 55. LifeScan Recent Development
Table 56. Abbott Laboratories Company Details
Table 57. Abbott Laboratories Business Overview
Table 58. Abbott Laboratories Diabetes Testing Program Product
Table 59. Abbott Laboratories Revenue in Diabetes Testing Program Business (US$ Million), 2021–2026
Table 60. Abbott Laboratories Recent Development
Table 61. Ascensia Company Details
Table 62. Ascensia Business Overview
Table 63. Ascensia Diabetes Testing Program Product
Table 64. Ascensia Revenue in Diabetes Testing Program Business (US$ Million), 2021–2026
Table 65. Ascensia Recent Development
Table 66. Arkray Company Details
Table 67. Arkray Business Overview
Table 68. Arkray Diabetes Testing Program Product
Table 69. Arkray Revenue in Diabetes Testing Program Business (US$ Million), 2021–2026
Table 70. Arkray Recent Development
Table 71. I-SENS Company Details
Table 72. I-SENS Business Overview
Table 73. I-SENS Diabetes Testing Program Product
Table 74. I-SENS Revenue in Diabetes Testing Program Business (US$ Million), 2021–2026
Table 75. I-SENS Recent Development
Table 76. Omron Company Details
Table 77. Omron Business Overview
Table 78. Omron Diabetes Testing Program Product
Table 79. Omron Revenue in Diabetes Testing Program Business (US$ Million), 2021–2026
Table 80. Omron Recent Development
Table 81. Braun Company Details
Table 82. Braun Business Overview
Table 83. Braun Diabetes Testing Program Product
Table 84. Braun Revenue in Diabetes Testing Program Business (US$ Million), 2021–2026
Table 85. Braun Recent Development
Table 86. Siemens Company Details
Table 87. Siemens Business Overview
Table 88. Siemens Diabetes Testing Program Product
Table 89. Siemens Revenue in Diabetes Testing Program Business (US$ Million), 2021–2026
Table 90. Siemens Recent Development
Table 91. Bio-Rad Laboratories Company Details
Table 92. Bio-Rad Laboratories Business Overview
Table 93. Bio-Rad Laboratories Diabetes Testing Program Product
Table 94. Bio-Rad Laboratories Revenue in Diabetes Testing Program Business (US$ Million), 2021–2026
Table 95. Bio-Rad Laboratories Recent Development
Table 96. Tosoh Company Details
Table 97. Tosoh Business Overview
Table 98. Tosoh Diabetes Testing Program Product
Table 99. Tosoh Revenue in Diabetes Testing Program Business (US$ Million), 2021–2026
Table 100. Tosoh Recent Development
Table 101. Danaher Corporation Company Details
Table 102. Danaher Corporation Business Overview
Table 103. Danaher Corporation Diabetes Testing Program Product
Table 104. Danaher Corporation Revenue in Diabetes Testing Program Business (US$ Million), 2021–2026
Table 105. Danaher Corporation Recent Development
Table 106. Trinity Biotech Company Details
Table 107. Trinity Biotech Business Overview
Table 108. Trinity Biotech Diabetes Testing Program Product
Table 109. Trinity Biotech Revenue in Diabetes Testing Program Business (US$ Million), 2021–2026
Table 110. Trinity Biotech Recent Development
Table 111. HUMAN Diagnostics Company Details
Table 112. HUMAN Diagnostics Business Overview
Table 113. HUMAN Diagnostics Diabetes Testing Program Product
Table 114. HUMAN Diagnostics Revenue in Diabetes Testing Program Business (US$ Million), 2021–2026
Table 115. HUMAN Diagnostics Recent Development
Table 116. Terumo Company Details
Table 117. Terumo Business Overview
Table 118. Terumo Diabetes Testing Program Product
Table 119. Terumo Revenue in Diabetes Testing Program Business (US$ Million), 2021–2026
Table 120. Terumo Recent Development
Table 121. Sinocare Company Details
Table 122. Sinocare Business Overview
Table 123. Sinocare Diabetes Testing Program Product
Table 124. Sinocare Revenue in Diabetes Testing Program Business (US$ Million), 2021–2026
Table 125. Sinocare Recent Development
Table 126. Acon Biotech Company Details
Table 127. Acon Biotech Business Overview
Table 128. Acon Biotech Diabetes Testing Program Product
Table 129. Acon Biotech Revenue in Diabetes Testing Program Business (US$ Million), 2021–2026
Table 130. Acon Biotech Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report
List of Figures
Figure 1. Diabetes Testing Program Picture
Figure 2. Global Diabetes Testing Program Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Diabetes Testing Program Market Share by Type: 2025 vs 2032
Figure 4. HbA1c Test Features
Figure 5. Finger-prick Test Features
Figure 6. Global Diabetes Testing Program Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Diabetes Testing Program Market Share by Application: 2025 vs 2032
Figure 8. Medical Diagnosis Case Studies
Figure 9. Home Test Case Studies
Figure 10. Lab Testing Case Studies
Figure 11. Diabetes Testing Program Report Years Considered
Figure 12. Global Diabetes Testing Program Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Diabetes Testing Program Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Diabetes Testing Program Market Share by Region: 2025 vs 2032
Figure 15. Global Diabetes Testing Program Market Share by Players in 2025
Figure 16. Global Diabetes Testing Program Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Diabetes Testing Program Revenue in 2025
Figure 18. North America Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Diabetes Testing Program Market Share by Country (2021–2032)
Figure 20. United States Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Diabetes Testing Program Market Share by Country (2021–2032)
Figure 24. Germany Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Diabetes Testing Program Market Share by Region (2021–2032)
Figure 32. China Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Diabetes Testing Program Market Share by Country (2021–2032)
Figure 40. Mexico Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Diabetes Testing Program Market Share by Country (2021–2032)
Figure 44. Israel Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Diabetes Testing Program Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Roche Revenue Growth Rate in Diabetes Testing Program Business (2021–2026)
Figure 48. LifeScan Revenue Growth Rate in Diabetes Testing Program Business (2021–2026)
Figure 49. Abbott Laboratories Revenue Growth Rate in Diabetes Testing Program Business (2021–2026)
Figure 50. Ascensia Revenue Growth Rate in Diabetes Testing Program Business (2021–2026)
Figure 51. Arkray Revenue Growth Rate in Diabetes Testing Program Business (2021–2026)
Figure 52. I-SENS Revenue Growth Rate in Diabetes Testing Program Business (2021–2026)
Figure 53. Omron Revenue Growth Rate in Diabetes Testing Program Business (2021–2026)
Figure 54. Braun Revenue Growth Rate in Diabetes Testing Program Business (2021–2026)
Figure 55. Siemens Revenue Growth Rate in Diabetes Testing Program Business (2021–2026)
Figure 56. Bio-Rad Laboratories Revenue Growth Rate in Diabetes Testing Program Business (2021–2026)
Figure 57. Tosoh Revenue Growth Rate in Diabetes Testing Program Business (2021–2026)
Figure 58. Danaher Corporation Revenue Growth Rate in Diabetes Testing Program Business (2021–2026)
Figure 59. Trinity Biotech Revenue Growth Rate in Diabetes Testing Program Business (2021–2026)
Figure 60. HUMAN Diagnostics Revenue Growth Rate in Diabetes Testing Program Business (2021–2026)
Figure 61. Terumo Revenue Growth Rate in Diabetes Testing Program Business (2021–2026)
Figure 62. Sinocare Revenue Growth Rate in Diabetes Testing Program Business (2021–2026)
Figure 63. Acon Biotech Revenue Growth Rate in Diabetes Testing Program Business (2021–2026)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Diabetes Testing Program market?
The top companies in the global Diabetes Testing Program market are Roche、LifeScan、Abbott Laboratories.
What was the global market size of Diabetes Testing Program in 2026?
What was the global market size of Diabetes Testing Program in 2032?
What is the annual compound growth rate of the global Diabetes Testing Program market size from 2026 to 2032?
Which region is expected to have the highest market share?
Related Reports
Global Diabetes Testing Program Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Diabetes Testing Program market size was US$ 2674 million in 2025 and is forecast to reach a readjusted size of US$ 4414 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 105
USD 4250.00
(Single User License)
Diabetes Testing Program - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diabetes Testing Program was estimated to be worth US$ 2674 million in 2025 and is projected to reach US$ 4414 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 137
USD 3950.00
(Single User License)
Global Diabetes Testing Program Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Diabetes Testing Program market size was US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 104
USD 4250.00
(Single User License)
Global Diabetes Testing Program Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Diabetes Testing Program market is projected to grow from US$ 2504 million in 2024 to US$ 4134 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 152
USD 4900.00
(Single User License)
Diabetes Testing Program- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetes Testing Program was estimated to be worth US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 129
USD 3950.00
(Single User License)
Global Diabetes Testing Program Market Research Report 2025
The global market for Diabetes Testing Program was valued at US$ 2504 million in the year 2024 and is projected to reach a revised size of US$ 4134 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published Date: 2025-01-19
Pages: 92
USD 2900.00
(Single User License)
Global and United States Diabetes Testing Program Market Report & Forecast 2024-2030
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published Date: 2024-04-19
Pages: 122
USD 4350.00
(Single User License)
Diabetes Testing Program- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published Date: 2024-04-19
Pages: 125
USD 3950.00
(Single User License)
Global Diabetes Testing Program Market Research Report 2024
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published Date: 2024-04-19
Pages: 99
USD 2900.00
(Single User License)
Global Diabetes Testing Program Market Insights, Forecast to 2030
Published Date: 2024-03-20
Pages: 197
USD 4900.00
(Single User License)
Global Diabetes Testing Program Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Diabetes Testing Program market size was US$ 2674 million in 2025 and is forecast to reach a readjusted size of US$ 4414 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 105
USD 4250.00 (Single User License)Diabetes Testing Program - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diabetes Testing Program was estimated to be worth US$ 2674 million in 2025 and is projected to reach US$ 4414 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-01-05
Pages: 137
USD 3950.00 (Single User License)Global Diabetes Testing Program Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Diabetes Testing Program market size was US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 104
USD 4250.00 (Single User License)Global Diabetes Testing Program Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Diabetes Testing Program market is projected to grow from US$ 2504 million in 2024 to US$ 4134 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 152
USD 4900.00 (Single User License)Diabetes Testing Program- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetes Testing Program was estimated to be worth US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 129
USD 3950.00 (Single User License)Global Diabetes Testing Program Market Research Report 2025
The global market for Diabetes Testing Program was valued at US$ 2504 million in the year 2024 and is projected to reach a revised size of US$ 4134 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published: 2025-01-19
Pages: 92
USD 2900.00 (Single User License)Global and United States Diabetes Testing Program Market Report & Forecast 2024-2030
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published: 2024-04-19
Pages: 122
USD 4350.00 (Single User License)Diabetes Testing Program- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published: 2024-04-19
Pages: 125
USD 3950.00 (Single User License)Global Diabetes Testing Program Market Research Report 2024
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published: 2024-04-19
Pages: 99
USD 2900.00 (Single User License)Global Diabetes Testing Program Market Insights, Forecast to 2030
Published: 2024-03-20
Pages: 197
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now